Cereno Scientific has broadened the clinical development focus of its [...]
Qureight, a techbio company advancing the understanding of lung and [...]
Cereno Scientific, a biotechnology company pioneering treatments for rare cardiovascular [...]
Qureight’s deep-learning biomarkers confirm representativeness of Insilico’s Phase 2a IPF [...]